Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient TEC
NCT06251076Phase 4Recruiting
- Sponsor
- University Health Network
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of teclistamab in multiple myeloma (MM), sponsored by University Health Network. Started Nov 2024; status: recruiting.
02
Drugs
teclistamab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06251076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06251076.